Adelphi Trust’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$681K Sell
568
-204
-26% -$208K 0.45% 56
2026
Q1
$710K Sell
772
-83
-10% -$84.1K 0.58% 51
2025
Q4
$919K Buy
+855
New +$818K 0.75% 37

Other funds holding LLY

Adelphi Trust's LLY Position: Q2 2026 in Review

Adelphi Trust reduced its Eli Lilly (LLY) stake by 26% in Q2 2026, selling an estimated $208K and leaving 568 shares worth $681K. The position accounts for 0.45% of the portfolio, ranked #56.

Adelphi Trust first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. The position peaked at $919K in Q4 2025. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Adelphi Trust held 568 shares of Eli Lilly worth $681K as of Q2 2026.
  • Adelphi Trust sold 204 Eli Lilly shares in Q2 2026, an estimated $208K.
  • Eli Lilly made up 0.45% of Adelphi Trust's portfolio in Q2 2026, its #56 holding.
  • Adelphi Trust first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • Adelphi Trust's Eli Lilly position peaked at $919K in Q4 2025.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Adelphi Trust's 13F filing for Q2 2026, filed 1 Jul 2026.